Creative Medical Technology Raises $4.5M, Reprices Warrants to $1.60, Issues New Warrants
CELZ sits 52% above its 52-week low of $0.79.
Summary
Creative Medical Technology raised $4.5 million by inducing existing warrant holders to exercise their warrants. The exercise price was reduced from $2.86 to $1.60 per share, and the company issued new inducement warrants for 5,580,680 shares at $1.60. This financing follows an 8-K filed earlier today and an S-1/A filed on June 26th detailing a public offering. The $4.5 million provides critical working capital for the company, which reported zero revenue and a $1.48 million decrease in cash for Q1 2026. However, the repricing and issuance of over 5.5 million new warrants represent significant potential dilution for current shareholders. Shareholder approval is required for the new warrants to become exercisable, which is part of a PRE 14A filing from July 1st seeking approval for an increase in authorized shares.
At the time of this announcement, CELZ was trading at $1.20 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $4.5M. The 52-week trading range was $0.79 to $6.25. This news item was assessed with neutral market sentiment and an importance score of 9 out of 10. Source: Wiseek News.